 |
 |
|
|
RESÚMENES JULIO 2004 |
Psychotic Disorders & Antipsychotics
Antipsychotics and
the Risk of Sudden Cardiac Death
Sabine
M. J. M. Straus, Gysčle S. Bleumink,
Jeanne P. Dieleman, Johan van der
Lei, Geert W. ‘t Jong, J. Herre Kingma, Miriam C. J. M. Sturkenboom, Bruno H. C. Stricker
Arch Intern Med. 2004;164:1293-1297
Pituitary volume in psychosis
Carmine M. Pariante, Konstantina Vassilopoulou, Dennis
Velakoulis, Lisa Phillips, Bridget Soulsby,
Stephen J. Wood, Warrick Brewer, Deidre J. Smith, Paola Dazzan, Alison R. Yung, Ioannis
M. Zervas, George N. Christodoulou, Robin Murray,
Patrick D. McGorry, Christos Pantelis
The British Journal of Psychiatry (2004) 185: 5-10
Cumulative incidence of mental disorders among offspring of mothers
with psychotic disorder. Results from the
Laura T. Niemi, Jaana M. Suvisaari, Jari K. Haukka, Gunnel Wrede, and Jouko K. Lönnqvist
The British Journal of Psychiatry (2004) 185: 11-17
Predictors
of antipsychotic treatment response in patients with first-episode
schizophrenia, schizoaffective and schizophreniform
disorders
Diana Perkins, Jeffrey Lieberman, Hongbin
Gu, Mauricio Tohen, Joseph McEvoy, Alan Green, Robert Zipursky,
Stephen Strakowski, Tonmoy
Sharma, René Kahn, Raquel Gur, Gary Tollefson,
the HGDH Research
Group
The British Journal of Psychiatry (2004) 185: 18-24
Explanatory models of illness in
schizophrenia: comparison of four ethnic groups
Rosemarie McCabe, and Stefan Priebe
The British Journal of Psychiatry (2004) 185: 25-30
Rapid tranquillisation of violent or agitated
patients in a psychiatric emergency setting. Pragmatic randomised
trial of intramuscular lorazepam v. haloperidol plus promethazine
Jacob Alexander, Prathap Tharyan, Clive Adams, Thomas John, Carina Mol, Joncy Philip
The British Journal of Psychiatry (2004) 185: 63-69
Higher Rates of Cigarette Smoking in Male
Adolescents Before the Onset of Schizophrenia: A
Historical-Prospective Cohort Study
Mark Weiser, Abraham Reichenberg,
Itamar Grotto, Ross Yasvitzky,
Jonathan Rabinowitz, Gad Lubin,
Daniella Nahon, Haim Y. Knobler, and Michael
Davidson
Am J Psychiatry 161:1219-1223, July 2004
Medical Decision Making in Antipsychotic
Drug Choice for Schizophrenia
Johannes Hamann, Bernadette Langer,
Stefan Leucht, Raymonde Busch, and Werner Kissling
Am J Psychiatry 161:1301-1304, July 2004
Insight into current symptoms of
schizophrenia. Association with frontal
cortical function and affect
Freudenreich, O.; Deckersbach, T.; Goff, DC
Acta Psychiatrica
Scandinavica.
110(1):14-20, July 2004
Neurological soft signs discriminating mood
disorders from first episode schizophrenia
Boks, M. P. M.; Liddle, P. F.; Burgerhof, J. G. M.; Knegtering, R.; van den
Bosch, R.-J
Acta Psychiatrica
Scandinavica. 110(1):29-35, July 2004
Dose response and atypical antipsychotics in schizophrenia
Kinon BJ, Ahl J, Stauffer VL, Hill AL, Buckley PF
CNS Drugs. 2004;18(9):597-616
The prevalence of the metabolic syndrome in
patients with schizoaffective disorder - bipolar subtype
Basu R, Brar JS, Chengappa KNR, John V, Parepally H, Gershon S, Schlicht P, Kupfer DJ
Bipolar Disord 2004: 6:
314-318
A Comparison of Risperidone-Induced
Weight Gain Across the Age Span
Safer, Daniel J
Journal of Clinical
Psychopharmacology. 24(4):429-436,
August 2004
Diabetes, Tardive Dyskinesia, Parkinsonism, and Akathisia
in Schizophrenia: A Retrospective Study Applying 1998 Diabetes Health Care
Guidelines to Antipsychotic Use
Can J Psychiatry 2004;49:398-401
Combination of "atypical"
antipsychotic medication in the management of treatment-resistant schizophrenia
and schizoaffective disorder
Vladimir
Lerner, Igor Libov, Moshe Kotler
and Rael D. Strous
Progress in Neuro-Psychopharmacology and Biological
Psychiatry Volume 28, Issue 1 , January 2004, Pages
89-98
Olanzapine
versus clozapine in treatment-resistant or
treatment-intolerant schizophrenia
Istvan Bitter, Martin R. K. Dossenbach, Shlomo Brook, Peter
D. Feldman, Stephen Metcalfe, Carlo A. Gagiano, János Füredi, György
Bartko, Zoltan Janka, Csaba M. Banki, Gabor Kovacs, Alan Breier
and for the Olanzapine HGCK Study Group.
Progress in Neuro-Psychopharmacology and Biological
Psychiatry Volume 28, Issue 1 , January 2004, Pages
173-180
Length of stay and antipsychotic treatment costs of
patients with acute psychosis admitted to hospital in
Salvador Peiró, Gregorio Gómez,
Montserrat Navarro, Iris Guadarrama,
Javier Rejas and for the Psychosp
group
Social Psychiatry and Psychiatric Epidemiology 2004;
Volume 39, Number 7: 507 – 513
Ten
Years of clinical experience with clozapine about 170
patients
Levoyer D, Martinet JP, Badiche A, Millet B
Encephale. 2004 May-Jun;30(3):285-95
The effects
of antipsychotic therapy on serum lipids: a comprehensive review
S. Sheremata and Y. Chen
Schizophrenia
Research Volume 70, Issue 1 , 1 September 2004, Pages
81-89
Adjunctive Fluvoxamine Inhibits Clozapine-Related
Weight Gain and Metabolic Disturbances
Mong-Liang Lu,
J
Clin Psychiatry 2004;65:766-771
A Survey of
Reports of Quetiapine-Associated Hyperglycemia and Diabetes
Mellitus
Elizabeth A. Koller, Jena Weber, P.
Murali Doraiswamy, and Bruce S. Schneider
J
Clin Psychiatry 2004;65:857-863
Second-generation
antipsychotics: Are their similarities greater than
their differences?
European Psychiatry 2003;18(SUPPL.
2):38s-45s
Human
Psychopharmacology 2004;19(2):111-119
Poyurovsky M,
Tal V, Maayan R, Gil-Ad I, Fuchs C, Weizman A
Eur Neuropsychopharmacol
2004;14(4):332-336
Severe
adverse drug reactions in psychiatric inpatients treated with neuroleptics
Bender S,
Grohmann R, Engel RR, Degner D, Dittmann-Balcar A, Ruther E
Pharmacopsychiatry 2004;37(SUPPL.
1):S46-S53
Severe and uncommon
involuntary movement disorders due to psychotropic drugs
Stubner S, Rustenbeck
E, Grohmann R, et al
Pharmacopsychiatry 2004;37(SUPPL.
1):S54-S64
Galactorrhea due to psychotropic drugs
Kropp S, Ziegenbein M, Grohmann R, Engel RR, Degner D
Pharmacopsychiatry 2004;37(SUPPL.
1):S84-S88
Kinon BJ, Ahl
J, Rotelli MD, McMullen E
Am
J Emerg Med 2004;22(3):181-186
Nicotine
improves delayed recognition in schizophrenic patients
Psychopharmacology
2004; Volume 174, Number 3: 334 - 340
Effects of
haloperidol on cholinergic striatal interneurons: relationship to oral dyskinesias
J.
J. Kelley and R. C. Roberts
Journal
of Neural Transmission 2004; Volume 111, Number 8: 1075 - 1091
GSK-3 beta in
cerebrospinal fluid of schizophrenia patients
N. Kozlovsky, W. T. Regenold,
J. Levine, A. Rapoport, R. H. Belmaker and G. Agam
Journal
of Neural Transmission 2004; Volume 111, Number 8: 1093 - 1098
Regulation of
central dopamine-2 receptor sensitivity by a proportional control thermostat in
humans
Dimensions of
major psychoses: a confirmatory factor analysis of six competing models
Neuroreport.
15(3):523-526, March 1, 2004
Wang C-Y,
Zhang Z-J, Li W-B, et al
J
Clin Pharmacol 2004;44(7):785-792
Turcynski J, Bidzan L, Staszewska-Malys E
Medical
Science Monitor 2004;10(5):I74-I80.
Clinical
utilization of atypical antipsychotics in pregnancy
and lactation
Ann
Pharmacother 2004;38(7-8):1265-1271
The use of antiparkinsonian agents in the management of drug-induced extrapyramidal symptoms
Burgyone K, Aduri K, Ananth
J, Parameswaran S
Curr Pharm Des 2004;10(18):2239-2248
Ananth J, Parameswaran S, Gunatilake S
Curr Pharm Des 2004;10(18):2231-2238
COX-2
inhibitors as adjunctive therapy in schizophrenia
Norbert
Müller; Martin Strassnig; Markus J Schwarz; Markus Ulmschneider; Michael Riedel
Expert
Opinion on Investigational Drugs .2004, vol. 13, no. 8, pp. 1033 - 1044 A preliminary study
of the comparative effects of olanzapine and risperidone on cognition in schizophrenia Australian
and New Zealand Journal of Psychiatry
2004; Volume: 38 Number: 7 Page: 501 -- 510 Jue He, Haiyun
Xu, Yi Yang, Xia Zhang and Xin-Min
Li How antipsychotics become
anti-‘psychotic’ – from dopamine to salience to psychosis Shitij Kapur Effect of
switching to atypical antipsychotics on memory in
patients with chronic schizophrenia 
Kim YT, Kang BJ
Hum Psychopharmacol.
2004 Jun;19(4):265-9
Brain
Research.Volume 1018, Issue 2 ,
27 August 2004, Pages 186-192
Trends in Pharmacological Sciences. Volume
25, Issue 8 , 1 August 2004, Pages 402-406